Skip to main content

Vaxxinity, Inc.

VAXXDelisted Apr 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001851657

Vaxxinity, Inc. was delisted on Apr 29, 2024; its insiders filed their last Form 4 on Apr 29, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $8.73M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Vaxxinity, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Vaxxinity, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Vaxxinity, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Ray SumitaChief Legal, Comp & Admin Off–Apr 29, 20240
Paula Molina ReneSee Remarks–Nov 3, 20230
Powchik PeterDirector–Oct 11, 20230
Prime Movers Lab Fund I LP10% Owner3,594,122IndirectSep 8, 20230
Sloss Dakin10% Owner3,594,122IndirectSep 8, 20230
Hornig George RDirector–Jun 26, 20230
Toledano Gabrielle BDirector–Jun 26, 20230
Diamandis PeterDirector906,141Jun 26, 20230
Eade Katherine A.Director–Jun 26, 20230
Smith James AlanDirector–Jun 26, 20230
Ogilvie Landon EDirector–Jun 26, 20230
Hu Mei MeiSee Remarks51,737,344IndirectApr 5, 20230
Reese LouSee Remarks51,737,344IndirectApr 5, 20230
Palm UloSee Remarks450IndirectApr 4, 20230
Pesile JasonSee Remarks–Apr 4, 20230
Guirakhoo Farshad(Former) Chief Scientific Off.68,645Aug 29, 20220
Blatt Gregory RDirector76,923Jun 23, 20220
Chui JamesDirector14,000Jun 23, 20220
United Biomedical Inc10% Owner51,737,344Jun 21, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2023 (view filing)6:05 PM ETSep 6-82 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−14.0K$1.80−$25.1K−1.7%831.7K after7 lots
Sep 8, 2023 (view filing)6:05 PM ETSep 6-72 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−25.6K$1.81−$46.3K−0.3%8.74M after2 lots
Sep 8, 2023 (view filing)6:05 PM ETSep 7-81 dayPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−32.3K$1.71−$55.3K−0.9%3.59M after5 lots
Sep 8, 2023 (view filing)6:05 PM ETSep 8Same dayPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−25.1K$1.67−$41.9K−0.3%8.71M after
Jan 25, 2023 (view filing)5:58 PM ETJan 232 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−95.5K$3.35−$320.0K−4.4%2.07M after
Jan 25, 2023 (view filing)5:58 PM ETJan 232 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−405.2K$3.35−$1.36M−4.4%8.76M after
Dec 5, 2022 (view filing)5:31 PM ETDec 1-24 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−66.5K$2.96−$196.5K−3.0%2.16M after2 lots
Dec 5, 2022 (view filing)5:31 PM ETDec 1-24 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−282.1K$2.96−$833.8K−3.0%9.17M after2 lots
Sep 8, 2022 (view filing)4:55 PM ETSep 62 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−12.1K$2.40−$29.1K−0.8%1.47M after3 lots
Sep 8, 2022 (view filing)4:55 PM ETSep 62 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−25.2K$2.40−$60.7K−0.3%9.45M after
Aug 25, 2022 (view filing)6:02 PM ETAug 23-242 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−56.4K$2.40−$135.6K−3.7%1.48M after6 lots
Aug 25, 2022 (view filing)6:02 PM ETAug 23-242 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−117.6K$2.40−$282.6K−1.2%9.50M after2 lots
Aug 25, 2022 (view filing)6:02 PM ETAug 25Same dayPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−10.9K$2.33−$25.5K−0.7%1.48M after3 lots
Aug 25, 2022 (view filing)6:02 PM ETAug 25Same dayPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A common stock−22.8K$2.33−$53.0K−0.2%9.48M after
Jun 23, 2022 (view filing)Nov 18, 2021217 daysDiamandis PeterDirectorSSaleClass A common stock−248$13.00−$3.22K−0.3%90.5K afterAmended
Jun 21, 2022 (view filing)Jun 165 daysReese LouExecutive ChairmanPPurchaseClass A common stock+100.0K$1.99+$199.0K+0.2%51.7M afterDuplicate filing
Jun 21, 2022 (view filing)Jun 165 daysHu Mei MeiSee RemarksPPurchaseClass A common stock+100.0K$1.99+$199.0K+0.2%51.7M afterDuplicate filing
Jun 21, 2022 (view filing)Jun 165 daysUnited Biomedical Inc10% OwnerPPurchaseClass A common stock+100.0K$1.99+$199.0K+0.2%51.7M after
Jun 14, 2022 (view filing)7:08 PM ETJun 10-134 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−58.1K$2.51−$145.9K−3.7%1.50M after6 lots
Jun 14, 2022 (view filing)7:08 PM ETJun 10-134 daysPrime Movers Lab Fund I LP and 1 other10% OwnerSSaleClass A Common Stock−120.9K$2.51−$304.0K−1.2%9.62M after2 lots
Jun 10, 2022 (view filing)Jun 8-92 daysUnited Biomedical Inc10% OwnerPPurchaseClass A common stock+21.0K$2.83+$59.4K0.0%51.6M after2 lotsDuplicate filing
Jun 10, 2022 (view filing)Jun 8-92 daysHu Mei MeiSee RemarksPPurchaseClass A common stock+21.0K$2.83+$59.4K0.0%51.6M after2 lotsDuplicate filing
Jun 10, 2022 (view filing)Jun 8-92 daysReese LouExecutive ChairmanPPurchaseClass A common stock+21.0K$2.83+$59.4K0.0%51.6M after2 lots
Apr 28, 2022 (view filing)Apr 26-272 daysUnited Biomedical Inc10% OwnerPPurchaseClass A common stock+22.9K$3.48+$79.7K0.0%51.6M after2 lotsDuplicate filing
Apr 28, 2022 (view filing)Apr 26-272 daysReese LouExecutive ChairmanPPurchaseClass A common stock+22.9K$3.48+$79.7K0.0%51.6M after2 lotsDuplicate filing
Apr 28, 2022 (view filing)Apr 26-272 daysHu Mei MeiSee RemarksPPurchaseClass A common stock+22.9K$3.48+$79.7K0.0%51.6M after2 lots
Apr 27, 2022 (view filing)Apr 252 daysHu Mei MeiSee RemarksPPurchaseClass A common stock+8.04K$3.37+$27.1K0.0%51.6M afterDuplicate filing
Apr 27, 2022 (view filing)Apr 252 daysReese LouExecutive ChairmanPPurchaseClass A common stock+8.04K$3.37+$27.1K0.0%51.6M after
Apr 27, 2022 (view filing)Apr 252 daysUnited Biomedical Inc10% OwnerPPurchaseClass A common stock+8.04K$3.37+$27.1K+0.2%5.19M after
Jan 6, 2022 (view filing)Dec 31, 20216 daysLateChui JamesDirectorPPurchaseClass A common stock+6.00K$5.48+$32.9K+75.0%14.0K after
Dec 14, 2021 (view filing)Dec 104 daysChui JamesDirectorPPurchaseClass A common stock+8.00K$7.89+$63.1KNew position8.00K after
Nov 15, 2021 (view filing)Nov 15Same dayBlatt Gregory RDirectorPPurchaseClass A common stock+76.9K$0.00$0New position76.9K after
Nov 15, 2021 (view filing)Nov 15Same dayPalm UloChief Medical OfficerPPurchaseClass A common stock+450$13.00+$5.85KNew position450 after
Nov 15, 2021 (view filing)Nov 123 daysReese LouExecutive ChairmanPPurchaseClass A common stock+17.5K$13.82+$241.8KNew position17.5K afterDuplicate filing
Nov 15, 2021 (view filing)Nov 123 daysHu Mei MeiSee RemarksPPurchaseClass A common stock+17.5K$13.82+$241.8KNew position17.5K after